# RB-PDT for Fusarium Keratitis: The LUMIERE Study

> **NCT07743489** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Stanford University** · enrollment: 434 (estimated)

## Conditions studied

- Fusarium Keratitis

## Interventions

- **DRUG:** Rose Bengal Photodynamic Therapy
- **DRUG:** Sham RB-PDT

## Key facts

- **NCT ID:** NCT07743489
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2029-04
- **Final completion:** 2030-01
- **Target enrollment:** 434 (ESTIMATED)
- **Last updated:** 2026-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743489, "RB-PDT for Fusarium Keratitis: The LUMIERE Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*